Bupropion Hydrochloride Tablet, Film Coated, Extended Release
Product Images NDC 43598-536

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Bupropion Hydrochloride (NDC 43598-536). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr. Reddy�s Laboratories Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bupropion-hydrochloride-sr-1 (Bupropion Hydrochloride Sr 1)

FDA Label Image

Bupropion-label1 (Bupropion Label1)

FDA Label Image

Bupropion-label2 (Bupropion Label2)

This is a medication called Bupropion HCI, which is an extended-release tablet that needs to be taken twice a day. It comes with a Medication Guide that should be dispensed by the pharmacist along with the tablets. The warning advises against using this medicine in combination with ZYBAN® or any other medicine containing bupropion hydrochloride. The strength of the tablet is 100mg of Bupropion HCI USP. The manufacturer's name and some codes are also included in the text.*

FDA Label Image

Bupropion-label3 (Bupropion Label3)

FDA Label Image

Bupropion-label4 (Bupropion Label4)

This appears to be a medication label. The medication is Bupropion HCI Extended-Release Tablets, USP (SR), 150 mg. The label includes the warning to not use with ZYBRNE or other medications that contain bupropion. The height measurement of the tablet is noted as 1.5". The remaining text appears to be garbled or not recognized by .*

FDA Label Image

Bupropion-label5 (Bupropion Label5)

FDA Label Image

Bupropion-label6 (Bupropion Label6)

FDA Label Image

Bupropion-label7 (Bupropion Label7)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.